Abstract
Introduction: Several studies reported an increased incidence of gestational diabetes mellitus (GDM) during the COVID-19 pandemic
We describe our monocentric cohort of GDM patients in 2021 and compare it with a previous cohort of 2017.
Material and methods: We performed a review of the inpatient clinic pregnancies that presented between January 1st and March 31st , 2021
We reported the main issues for the mother- baby dyads and compared them with a previous study before the COVID-19 crisis (October 1st to December 31st, 2017)
Results: There were 110 GDM pregnant patients (13.44%) in the 2021 COVID-19 cohort, versus 94(6.2%) in the 2017 cohort
A chi-square test of independence was performed to examine the relation between GDM and COVID-19 pandemic : the relation between these variables was significant, X2 = 34.9823, p < 0.00001.
We also compared the incidence of neonatal macrosomia, and the test revealed a significant relation, X2 = 5.9452, p =0.014758.
Discussion: The COVID-19 pandemic impacted negatively health of pregnant women, with a major increase on the incidence of GDM worlwide
We depict a glance of such negative effects of the SARS-CoV-2 epidemic and show a higher local incidence of GDM and macrosomia
Conclusion: The global COVID-19 pandemic led to an exponential increase in GDM cases, including in middle-income countries.
These cases seem to be associated with negative outcomes, particularly for the newborn.
Keywords: Gestational Diabetes Mellitus, Incidence, COVID-19, Macrosomia
Abbreviations: GDM: Gestational Diabetes Mellitus, COVID-19: Coronavirus Disease 2019, SARS-CoV-2: severe acute respiratory syndrome coronavirus 2
Funding and Conflicts of Interest
Nothing to disclose
